Salvia, R.; Rico, L.G.; Morán, T.; Bradford, J.A.; Ward, M.D.; Drozdowskyj, A.; Climent-MartÃ, J.; MartÃnez-Cáceres, E.M.; Rosell, R.; Petriz, J.
Prognostic Significance of PD-L1 Expression on Circulating Myeloid-Derived Suppressor Cells in NSCLC Patients Treated with Anti-PD-1/PD-L1 Checkpoint Inhibitors. Int. J. Mol. Sci. 2024, 25, 12269.
https://doi.org/10.3390/ijms252212269
AMA Style
Salvia R, Rico LG, Morán T, Bradford JA, Ward MD, Drozdowskyj A, Climent-Martà J, MartÃnez-Cáceres EM, Rosell R, Petriz J.
Prognostic Significance of PD-L1 Expression on Circulating Myeloid-Derived Suppressor Cells in NSCLC Patients Treated with Anti-PD-1/PD-L1 Checkpoint Inhibitors. International Journal of Molecular Sciences. 2024; 25(22):12269.
https://doi.org/10.3390/ijms252212269
Chicago/Turabian Style
Salvia, Roser, Laura G. Rico, Teresa Morán, Jolene A. Bradford, Michael D. Ward, Ana Drozdowskyj, Joan Climent-MartÃ, Eva M. MartÃnez-Cáceres, Rafael Rosell, and Jordi Petriz.
2024. "Prognostic Significance of PD-L1 Expression on Circulating Myeloid-Derived Suppressor Cells in NSCLC Patients Treated with Anti-PD-1/PD-L1 Checkpoint Inhibitors" International Journal of Molecular Sciences 25, no. 22: 12269.
https://doi.org/10.3390/ijms252212269
APA Style
Salvia, R., Rico, L. G., Morán, T., Bradford, J. A., Ward, M. D., Drozdowskyj, A., Climent-MartÃ, J., MartÃnez-Cáceres, E. M., Rosell, R., & Petriz, J.
(2024). Prognostic Significance of PD-L1 Expression on Circulating Myeloid-Derived Suppressor Cells in NSCLC Patients Treated with Anti-PD-1/PD-L1 Checkpoint Inhibitors. International Journal of Molecular Sciences, 25(22), 12269.
https://doi.org/10.3390/ijms252212269
